Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Revenue

Nykode Therapeutics AS had revenue of $240.00K USD in the quarter ending March 31, 2026, with 75.18% growth. This brings the company's revenue in the last twelve months to $556.00K, down -93.28% year-over-year. In the year 2025, Nykode Therapeutics AS had annual revenue of $453.00K, down -95.05%.

• Revenue (ttm): $556.00K
• Revenue Growth: -93.28%
• P/S Ratio: 197.19
• Revenue / Employee: $9.42K
• Employees: 59
• Market Cap: 1.07B NOK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	453.00K	-8.71M	-95.05%
Dec 31, 2024	9.16M	-4.17M	-31.26%
Dec 31, 2023	13.32M	4.29M	47.56%
Dec 31, 2022	9.03M	-26.74M	-74.76%
Dec 31, 2021	35.77M	-179.93M	-83.42%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error